Investors seeking stocks with explosive growth potential should consider the biotech industry. Drugmakers can experience ...

The chief medical officer of Genetix Biotherapeutics, formerly known as Bluebird bio, discusses timelines and operational ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers ...

After 15 years of research, a 10-minute injection transformed three-year-old Ollie’s life in ways once thought to be ...

The Oxford Student discusses a potential new gene therapy that shows promise in treating Huntington's disease.

Genetic engineering is moving from the lab bench into clinics, farms, and even family planning decisions, promising to change ...

Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...

The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and ...

Researchers have designed a chemical phototherapy tool that when exposed to blue light damages an enzyme found in ...